Table 2.

Cytologic analysis of BAL fluid




Primary pulmonary NHL; n = 12

Secondary pulmonary NHL; n = 8

Nonlymphomatous pulmonary lesions; n = 71

Undetermined pulmonary diagnosis; n = 6
Cell count, mean (range)     
Total cell count, × 109/L   0.542 (0.18-2.3)   0.396 (0.152-1.08)   0.481 (0.051-3.6)   0.450 (0.09-0.92)  
Neutrophils, %   4 (0-20)   17 (0-50)   13 (0-85)   36 (1-77)  
Eosinophils, %   0.8 (0-2)   0.38 (0-1)   2.3 (0-19)   3.3 (0-17)  
Macrophages, %   58 (18-93)   48 (10-81)   47 (5-92)   42 (10-74)  
Lymphocytes, %   36 (3-81)   30 (3-61)   40 (1-89)   18 (6-39)  
Cytology     
No. samples with atypical lymphocytes   6   3   1   0  
Lymphocyte phenotype     
Number of studied samples   7   2   29   1  
CD3, % (range)   58 (27-90)   98-79   91 (52-98)   87  
CD4, % (range)   35 (11-77)   28-21   58 (2-93)   17  
CD8, % (range)   23 (8-56)   71-24   40 (4-92)   69  
CD19, % (range)
 
37 (9-62)
 
0-18
 
1.8 (0-12)
 
0
 



Primary pulmonary NHL; n = 12

Secondary pulmonary NHL; n = 8

Nonlymphomatous pulmonary lesions; n = 71

Undetermined pulmonary diagnosis; n = 6
Cell count, mean (range)     
Total cell count, × 109/L   0.542 (0.18-2.3)   0.396 (0.152-1.08)   0.481 (0.051-3.6)   0.450 (0.09-0.92)  
Neutrophils, %   4 (0-20)   17 (0-50)   13 (0-85)   36 (1-77)  
Eosinophils, %   0.8 (0-2)   0.38 (0-1)   2.3 (0-19)   3.3 (0-17)  
Macrophages, %   58 (18-93)   48 (10-81)   47 (5-92)   42 (10-74)  
Lymphocytes, %   36 (3-81)   30 (3-61)   40 (1-89)   18 (6-39)  
Cytology     
No. samples with atypical lymphocytes   6   3   1   0  
Lymphocyte phenotype     
Number of studied samples   7   2   29   1  
CD3, % (range)   58 (27-90)   98-79   91 (52-98)   87  
CD4, % (range)   35 (11-77)   28-21   58 (2-93)   17  
CD8, % (range)   23 (8-56)   71-24   40 (4-92)   69  
CD19, % (range)
 
37 (9-62)
 
0-18
 
1.8 (0-12)
 
0
 
Close Modal

or Create an Account

Close Modal
Close Modal